Facetime with Phil: Off-Label Drug Use: Potential Impact on Workers’ Compensation
In the fourth and final Facetime with Phil video blog on Off-Label Drug Use, myMatrixx Chief Clinical Officer, Phil Walls, discusses the potential dangers that may accompany the use of drugs like Subsys (fentanyl sublingual spray) for reasons other than their intended use.
OTHER VIDEOS IN THIS SERIES
FDA’S NEW POSITION ON OFF-LABEL DRUG USE
OFF-LABEL VS. INVESTIGATIONAL DRUG USE